Louisiana AG Election to Name Enforcer, Defender of 340B Contract Pharmacy Law

Democrat Lindsey Cheek (left) and Republican Elizabeth Murrill (right) are running to be the next Louisiana attorney general.
A November election for Louisiana attorney general will determine the primary official who both enforces its 340B contract pharmacy law [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Biocon Announces New NDC for its Lantus Biosimilar

Biocon
Biocon has added a new national drug code for its insulin biosimilar, the drugmaker recently notified 340B providers.
Indian biopharmaceutical manufacturer Biocon Biologics has notified 340B covered entities about a new national drug code (NDC) for insulin glargine-yfgn, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Column: Look to The Senate for 340B Action

Ted Slafsky, publisher and CEO of 340B Report, writes the second part of his two-part column on the Senate "group of six" 340B discussion draft.
According to our history lessons, George Washington told Thomas Jefferson that the Senate was created to serve as a saucer [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Expert Tip from Cervey

img
img

TIP: Identify viable contract pharmacy opportunities for 340B registration to maximize savings.


How to Identify

Read More »

Genentech Asks Hospitals to Check 340B Split-Billing Software Settings

Genentech building
Genentech gave advanced notice to 340B hospitals that the drugmaker would implement 340B contract pharmacy restrictions on May 1.
Drug manufacturer Genentech has asked health systems and hospitals about possible 340B program compliance violations involving split-billing software settings. Staff [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

CMS Seeks Input on Contractor to Prevent 340B, Medicare Maximum Price Duplication

Kelsey Lang Avalere
Kelsey Lang, a health policy principal at Avalere, said CMS's request for information affirms its interest in preventing 340B duplicate discounts.
Regulators are seeking input on a contractor to help it shield drug manufacturers from giving duplicate 340B discounts and new [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

5 Best Practices for Running and Optimizing a Mixed-Use Program

SPONSORED CONTENT

To ensure compliance, maximize savings, and streamline operations, consider these five best practices.

1. Proficiency in Data Management

To effectively manage your 340B program, it’s crucial to comprehend how data is created, stored, and transmitted to your Third-Party Administrator (TPA). Typically, data is extracted from your Electronic Health Record (EHR) system to generate a flat file. This file is then ingested by your TPA, who calculates your accumulations for 340B savings, Group Purchasing Organization (GPO), and Wholesale Acquisition Cost (WAC) pricing.

A central aspect of effective data stewardship involves interpreting the data elements. Whether it’s Charge Description Masters (CDMs), National Drug Codes (NDCs), or a combination, understanding the codes and quantities is essential for correct accumulation and compliance. Analyzing charge data includes grasping the NDCs sent to your TPAs, deciphering charge quantities, and accounting for various units such as mL, mg, or shots administered.

To get to the place where you

Read More »

Teva Adds Drug to Hospital Contract Pharmacy Restriction Policy

Drugmaker Teva recently added its medication Austedo to its list of drugs under 340B contract pharmacy restrictions for hospitals.
Drug manufacturer Teva this week added a drug to the hospital contract pharmacy restrictions it first implemented in June. The [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Congressional Witnesses Urge Medicare 340B Cuts

Dr. Debra Patt, executive vice president at Texas Oncology, testified during a House subcommittee hearing that the 340B program was "broken."
Witnesses recently told a U.S. House subcommittee that Congress should cut Medicare payments for 340B drugs. The House Energy and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

340B Dispute Resolution Final Rule Enters Last Stage of Regulatory Review

HHS signage and building
HRSA plans to host a webinar for federal grantees in the days leading up to the 2024 340B recertification period.
A final rule to implement the 340B administrative dispute resolution (ADR) process arrived this week at the last stage of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report